Polycystic Ovary Syndrome (PCOS) Diagnostic Algorithm
Polycystic Ovary Syndrome (PCOS) Diagnostic Algorithm
This algorithm describes laboratory testing for assessment of PCOS criteria and differential diagnosis of PCOS and assessment of comorbidities.
This algorithm describes laboratory testing for assessment of PCOS criteria and differential diagnosis of PCOS and assessment of comorbidities.
This urinary free cortisol (UFC) test, performed with a 24-hour urine specimen, is one of the preferred tests for screening for and diagnosing Cushing syndrome. This test may also be used to monitor for recurrence of Cushing disease [1]. In addition, when used in conjunction with the measurement of 24-hour urine cortisone, this test may help identify disorders caused by impaired activity of 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2), such as apparent mineralocorticoid excess (AME) syndrome [2].
UFC level is independent of corticosteroid-binding globulin and albumin levels; thus, UFC level can demonstrate increased bioavailable cortisol in patients with endogenous Cushing syndrome [1]. A UFC test with 24-hour urine specimen also has the advantage of averaging circadian and ultradian variations of cortisol secretion. An elevated UFC level may provide initial evidence for Cushing syndrome. Two or more positive results of UFC tests may establish the diagnosis of Cushing syndrome if non-neoplastic hypercortisolism (pseudo-Cushing syndrome) is excluded [1].
A late-night salivary cortisol (LNSC) test or dexamethasone suppression test (DST) can also be used to diagnose Cushing syndrome or monitor for Cushing disease. Choice of test should be based on clinical scenario [1]. When monitoring for recurrence of Cushing disease, UFC levels usually become abnormal after LNSC tests or DSTs do [1].
UFC testing is not recommended for screening for Cushing syndrome in individuals with impaired kidney function or polyuria [1]. Non-neoplastic hypercortisolism caused by obesity, psychiatric disorders, alcohol use disorder, and polycystic ovary syndrome may increase UFC levels.
In patients with AME syndrome, deficiency of 11beta-HSD2 impairs the deactivation of cortisol to cortisone. Similarly, ingestion of certain compounds that inhibit 11beta-HSD2 activity, such as glycyrrhetinic acid (in licorice), carbenoxolone, and phthalates, may also reduce the conversion of cortisol to cortisone. Therefore, a high cortisol-to-cortisone ratio measured in 24-hour urine may help identify disorders caused by impaired activity of 11beta-HSD2 [2, 3].
The results of this test should be interpreted in the context of pertinent clinical and family history and physical examination findings.
Reference
1. Fleseriu M, et al. Lancet Diabetes Endocrinol. 2021;9(12):847-875.
2. Young WF, Jr., et al. Endocrine Reviews. 2017;38(2):103-122.
3. Carvajal CA, et al. J Clin Endocrinol Metab. 2020;105(4):dgz315.
DHEA-S is the sulfated form of DHEA and is the major androgen produced by the adrenal glands. This test is used in the differential diagnosis of hirsute or virilized female patients and for the diagnosis of isolated premature adrenarche and adrenal tumors. About 10% of hirsute women with Polycystic Ovarian Syndrome (PCOS) have elevated DHEA-S but normal levels of other androgens.
Salivary cortisol level, particularly late-night salivary cortisol (LNSC) level, is useful in screening for endogenous Cushing syndrome. Two or more positive results of LNSC tests may be used to confirm Cushing syndrome. LNSC measurement may also be used to monitor for recurrence of Cushing disease [1].
Normally, the secretion of cortisol has a circadian rhythm. Patients with Cushing syndrome often lose the late-night circadian nadir. Therefore, an elevated LNSC level may provide initial evidence for Cushing syndrome. Two or more positive results of LNSC tests may establish the diagnosis of Cushing syndrome if non-neoplastic hypercortisolism (pseudo-Cushing syndrome) is excluded. Because saliva is convenient to collect, LNSC testing is especially useful for individuals who need to provide multiple specimens over time for the evaluation of cyclic Cushing syndrome [1].
Annual LNSC testing is recommended to monitor for the recurrence of Cushing disease after pituitary surgery. LNSC testing may also be used in assessing treatment outcomes in patients receiving medical therapy for Cushing disease [1].
Non-neoplastic hypercortisolism caused by obesity, psychiatric disorders, alcohol use disorder, and polycystic ovary syndrome may increase LNSC levels. LNSC testing should not be used to screen for Cushing syndrome in individuals without normal day and night cycles. LNSC testing has low sensitivity in patients with adrenal tumors [1].
Other tests, such as urinary free cortisol (test code 14534) and dexamethasone suppression test (test code 6921), may also be used to screen for Cushing syndrome. Choice of tests should be individualized based upon clinical scenarios [1].
The results of this test should be interpreted in the context of pertinent clinical and family history and physical examination findings.
Reference
1. Fleseriu M, et al. Lancet Diabetes Endocrinol. 2021;9(12):847-875.
During pregnancy and postpartum lactation, serum prolactin can increase 10- to 20-fold. Exercise, stress, and sleep also cause transient increases in prolactin levels. Consistently elevated serum prolactin levels (>30 ng/mL), in the absence of pregnancy and postpartum lactation, are indicative of hyperprolactinemia. Hypersecretion of prolactin can be caused by pituitary adenomas, hypothalamic disease, breast or chest wall stimulation, renal failure or hypothyroidism. A number of drugs, including many antidepressants, are also common causes of abnormally elevated prolactin levels. Hyperprolactinemia often results in galactorrhea, amenorrhea, and infertility in females, and in impotence and hypogonadism in males. Renal failure, hypothyroidism, and prolactin-secreting pituitary adenomas are also common causes of abnormally elevated prolactin levels.
Reference ranges are provided as general guidance only. To interpret test results use the reference range in the laboratory report.
The tests listed by specialty and category are a select group of tests offered. For a complete list of Quest Diagnostics tests, please adjust the filter options chosen, or refer to our Directory of Services.